243 reports of this reaction
2.2% of all FLUVASTATIN SODIUM reports
#8 most reported adverse reaction
ASTHENIA is the #8 most commonly reported adverse reaction for FLUVASTATIN SODIUM, manufactured by Sandoz Inc. There are 243 FDA adverse event reports linking FLUVASTATIN SODIUM to ASTHENIA. This represents approximately 2.2% of all 11,133 adverse event reports for this drug.
Patients taking FLUVASTATIN SODIUM who experience asthenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ASTHENIA is a less commonly reported adverse event for FLUVASTATIN SODIUM, but still significant enough to appear in the safety profile.
In addition to asthenia, the following adverse reactions have been reported for FLUVASTATIN SODIUM:
The following drugs have also been linked to asthenia in FDA adverse event reports:
ASTHENIA has been reported as an adverse event in 243 FDA reports for FLUVASTATIN SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
ASTHENIA accounts for approximately 2.2% of all adverse event reports for FLUVASTATIN SODIUM, making it a notable side effect.
If you experience asthenia while taking FLUVASTATIN SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.